Skip to main content
. 2009 Oct 7;2009(4):CD002823. doi: 10.1002/14651858.CD002823.pub2

Palmer 2007.

Trial name or title ISRCTN12912789
Methods A randomised, sham‐controlled trial with 3 parallel arms
Randomisation method: not reported 
 Concealment of allocation: not reported
Blinding: not reported
Sample size calculation: not reported
Analyses: not reported whether is based on intention‐to‐treat principle
Trial duration: 6 weeks
Sponsored by: not reported
Participants 261 (87 in each arm) patients with primary knee OA to be randomised 
 Study joints: knees 
 Selection criteria: knee pain, radiographic (X‐ray) evidence of osteophytes, and at least 1 of the following 3 criteria: 50 years or older, morning stiffness that lasts for less than 30 minutes, crepitus on active movement
Interventions Experimental intervention: TENS, as much as needed and group education including self‐efficacy and exercise training, once per week 
 Control intervention 1: Sham TENS, as much as needed and group education once per week, as described above 
 Control intervention 2: group education once per week, as described above 
 Duration of treatment period: 6 weeks 
 Analgesics: unclear wether analgesic intake is allowed and is measured
Device: not reported 
 Self‐administered: yes 
 Waveform: not reported 
 Pulse width: not reported 
 Pulse frequency: not reported 
 Amplitude: "strong but comfortable" tingling sensation 
 Duration of stimulation: defined as "as much as needed" 
 Electrodes: not reported 
 Electrode placement: within or close to the site of pain
Sham device: identical in appearance, displays are active but there is no current output
Outcomes Primary outcome: WOMAC function subscale (at baseline, 3, 6, 12 and 24 weeks)
Secondary outcomes: 
 1. Total WOMAC score and WOMAC pain and stiffness subscale scores (at baseline, 3, 6, 12 and 24 weeks) 
 2. Knee extensor torque (quadriceps strength) (at baseline, 3, 6, 12 and 24 weeks) 
 3. Patient global assessment of change (at 3, 6, 12 and 24 weeks) 
 4. Self‐efficacy for exercise (at baseline and 24 weeks) 
 5. Self‐reported exercise adherence (at baseline, 3, 6, 12 and 24 weeks) 
 6. Logged TENS usage time (at 6 weeks)
Starting date 1 October 2007
Contact information Dr Shea Palmer 
 Faculty of Health and Social Care 
 University of the West of England 
 Blackberry Hill 
 Bristol 
 BS16 1DD 
 United Kingdom 
 Tel  +44 (0)117 328 8919 
 Email  Shea.Palmer@uwe.ac.uk 
Notes Status at 17 July 2009: completed at 30 June 2009

OA = osteoarthritis 
 TENS = transcutaneous electrical nerve stimulation 
 VAS = visual analogue scale